Intuitive Surgical (ISRG) has experienced a significant 30% decline in its stock price since the beginning of 2026, presenting a potential buying opportunity for aggressive growth investors. Despite this drop, the company’s fundamentals remain strong, with a 12% increase in the number of da Vinci surgical systems installed globally and a 17% year-over-year rise in procedures performed using these robots. This indicates robust demand for robotic surgery, which underpins Intuitive Surgical’s revenue, primarily derived from instruments, accessories, and services rather than just system sales.
The stock’s current price-to-earnings ratio of 51x, while high, is below its five-year average of 70x, suggesting that the stock may be undervalued in light of its growth potential. Historical performance shows that Intuitive Surgical has recovered from similar declines in the past, making this dip potentially temporary.
For market professionals, this situation highlights an opportunity to invest in a fundamentally sound business poised for long-term growth, particularly as the demand for robotic surgery continues to expand.
Source: fool.com